A detailed history of Globeflex Capital L P transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Globeflex Capital L P holds 139,194 shares of AMRX stock, worth $1.08 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
139,194
Previous 149,035 6.6%
Holding current value
$1.08 Million
Previous $946,000 22.41%
% of portfolio
0.11%
Previous 0.1%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$6.42 - $8.83 $63,179 - $86,896
-9,841 Reduced 6.6%
139,194 $1.16 Million
Q2 2024

Aug 13, 2024

BUY
$5.36 - $7.11 $78,609 - $104,275
14,666 Added 10.91%
149,035 $946,000
Q3 2023

Nov 13, 2023

SELL
$2.76 - $4.59 $16,101 - $26,778
-5,834 Reduced 4.16%
134,369 $567,000
Q2 2023

Aug 14, 2023

SELL
$1.33 - $3.1 $11,310 - $26,362
-8,504 Reduced 5.72%
140,203 $434,000
Q3 2021

Nov 12, 2021

SELL
$4.31 - $5.64 $1.41 Million - $1.84 Million
-326,045 Reduced 68.68%
148,707 $794,000
Q2 2021

Aug 12, 2021

BUY
$5.12 - $6.82 $2.31 Million - $3.07 Million
450,400 Added 1849.54%
474,752 $2.43 Million
Q1 2021

May 14, 2021

SELL
$4.74 - $7.38 $669,506 - $1.04 Million
-141,246 Reduced 85.29%
24,352 $164,000
Q4 2020

Feb 11, 2021

SELL
$3.95 - $5.42 $340,087 - $466,651
-86,098 Reduced 34.21%
165,598 $757,000
Q3 2020

Nov 13, 2020

BUY
$3.54 - $5.27 $38,996 - $58,054
11,016 Added 4.58%
251,696 $977,000
Q2 2020

Aug 12, 2020

BUY
$2.87 - $5.46 $144,923 - $275,708
50,496 Added 26.55%
240,680 $1.15 Million
Q1 2020

May 13, 2020

BUY
$2.46 - $5.35 $467,852 - $1.02 Million
190,184 New
190,184 $662,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.18B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.